- Home
- /
- Treatment
- /
- Page 20
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Genetically modified adeno-associated viral vector serotype 9 expressing shRNA as well as a codon-optimized shRNA-insensitive wildtype PABPN1 | Oculopharyngeal muscular dystrophy | Clinipace GmbH | January 12, 2017 | |
Human hepatoma cell line HepaRG in bioartificial liver | Acute liver failure | Hep-Art Medical Devices BV | January 12, 2017 | |
Non-replicating recombinant adeno-associated viral vector expressing the human acid alpha-glucosidase gene | Pompe disease | Duke University Medical Center;Box 103856;Durham, North Carolina, 27710 | January 11, 2017 | |
Human single domain antibody-like protein inhibitor of the chemokine receptor type 4 | Idiopathic pulmonary fibrosis | AdAlta Limited;15/2 Park Drive;Bundoora | January 11, 2017 | |
4-methylpiperazine-1-carboxylic acid [1-(3-benzenesufonyl-1-phenethylallyl-carbamoyl)-2-phenylethyl] amide | Chagas disease | Center for Discovery & Innovation in Parasitic Diseases;University of CA, San Francisco, 9500 Gilman Drive;LaJolla, California, 92093 | January 11, 2017 | |
Ritonavir powder for oral suspension | Use with other antiretroviral agents for the treatment of pediatric HIV-1 infection | AbbVie Inc.;Regulatory Affairs, 1 Waukegan Road;North Chicago, Illinois, 60044 | January 11, 2017 | |
Protoplasmic protein matrix, omega-3 fatty oils, vitamins, minerals and trace elements, cell membrane matrix phospholipid, entracellular matrix, lipids, medium chain triglycerides, longer chain triglycerides, carbohydrates, probiotic, and phytonutrients | Juvenile rheumatoid arthritis | Leonard S. Girsh, MD;Immunopath Profile, Ind., P. O. Box 770805;Naples, Florida, 34107 | January 11, 2017 | |
Monovalent replication-incompetent adenovirus serotype 26 (Ad26) vaccine, AD26.ZEBOV in combination with multivalent replication-defective Modified Vaccinia Ankara (MVA)-Bavarian Nordic (BN) vaccine, MVA-mBN226B | Ebola | Crucell Holland B.V.;Archimedesweg 4-6;Leiden | January 11, 2017 | |
Adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and the human alpha-L-iduronidase (hIDUA) gene | Hurler syndrome | Sangamo Therapeutics, Inc.;Point Richmond Tech Center, 501 Canal Boulevard;Richmond, California, 94804 | January 9, 2017 | |
Clenbuterol | Pompe disease | Dwight D. Koeberl, MD, PhD;Duke University Medical Center, Pediatrics Dept., Div. of Genetics;Durham, North Carolina, 27710 | January 9, 2017 | |
L-citrulline | Acute respiratory distress syndrome | Asklepion Pharmaceuticals, LLC;729 East Pratt Street, Suite 360;Baltimore, Maryland, 21202 | January 9, 2017 | |
Vancomycin HCL and Tobramycin sulfate multi-pack component of the Joint Purification Systems X7 Spacer | Periprosthetic joint infection | Joint Purification Systems LLC;c/o Cor Medical Ventures LLC, 215 S. Highway 101;Solana Beach, California, 92075 | January 9, 2017 | |
Glecaprevir and pibrentasvir | Pediatric patients with chronic hepatitis C virus infection | AbbVie, Inc.;1 Waukegan Road;North Chicago, Illinois, 60044 | January 9, 2017 | |
Celecoxib oral liquid suspension | Pediatric juvenile idiopathic arthritis | NuBioPharma, LLC;111 Dennis Drive, Suite 121;Sanford, North Carolina, 27330 | January 5, 2017 | |
Cytomegalovirus specific cytotoxic T lymphocytes | Cytomegalovirus infection in severely immunocompromised patients | ViraCyte, LLC;33 - 5th Avenue, NW, Suite 700;New Brighton, Minnesota, 55112 | January 5, 2017 | |
Ublituximab and phosphoinositide-3-kinase delta inhibitor | Chronic lymphocytic leukemia | TG Therapeutics, Inc.;2 Gansevoort Street, 9th Floor;New York, New York, 10014 | January 5, 2017 | |
(S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile | Dystrophic epidermolysis bullosa | Almirall, S.A.;Ctra. Laurea Miro, 408-410, Sant Feliu de Llobregat;Barcelona | January 5, 2017 | |
Echinomycin | Graft Versus Host Disease | OncoImmune, Inc.;502 E. Street, NE;Washington, District of Columbia, 20002 | January 5, 2017 | |
Emixustat | Stargardt Disease | Acucela Inc.;1301 2nd Avenue, Suite 4200;Seattle, Washington, 98101 | January 4, 2017 | |
Pyridoxal-5’ phosphate monohydrate (P5P) | Seizures associated with pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency | Medicure International Inc.;2-1250 Waverley Street;Winnipeg, Manitoba | January 4, 2017 | |
Pyridopyrimidinone SMN2 splicing modifier | Spinal muscular atrophy | Hoffmann-La Roche, Inc.;c/o Genentech, Inc., 1 DNA Way;South San Francisco, California, 94080 | January 4, 2017 | |
Humanized monoclonal antibody that blocks activity of complement component C5 | Hemoglobinuria | Alexion Pharmaceuticals, Inc.;55 Cambridge Parkway, Suite 800;Cambridge, Massachusetts, 02142 | January 4, 2017 | |
Lenalidomide | Splenic marginal zone lymphoma | Celgene Corporation;86 Morris Avenue;Summit, New Jersey, 07901 | January 4, 2017 | |
Lenalidomide | Nodal marginal zone lymphoma | Celgene Corporation;86 Morris Avenue;Summit, New Jersey, 07901 | January 4, 2017 | |
Pyridoxal-5� phosphate monohydrate (P5P) | Seizures associated with pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency | Medicure International Inc.;2-1250 Waverley Street;Winnipeg, Manitoba | January 4, 2017 |